Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 27 May 2020 |
2 | Reply to Exam Report (MIS-R) | 31 Jul 2020 |
3 | Documents in support of Show cause Hearing (SCH) | 21 May 2023 |
4 | TM-O(NOTICE OF OPPOSITION) | 10 May 2024 |
5 | Journal Copy | 22 May 2024 |
1 | EXAMINATION REPORT | 10134501 | 06 Jul 2020 | |
2 | Hearing Notice (Show Cause) | 13953322 | 17 Aug 2022 | |
3 | Hearing Notice (Show Cause) | 15008921 | 25 Mar 2023 | |
4 | Hearing Notice (Show Cause) | 16111658 | 25 Sep 2023 | |
5 | Hearing Notice (Show Cause) | 16795752 | 12 Dec 2023 | |
6 | Tribunal Accepted Notice for : 4510997 | 17050457 | 6438186 | 05 Jan 2024 |
7 | Opposition Notice | 18363981 | 6776365 | 21 Jun 2024 |
Trademark was applied on 27 May 2020 with IP India.
Proprietor of Covisafe is SUNCARE FORMULATIONS.
Class(es) in which the trademark was applied to is 3.
Status of Covisafe is Opposed.
Application number alloted to the trademark is 4510997.
Aegis Inc is the Trademark agent/attorney.
Trademark has been filed in the following category:
DEVICE